// App-Quantinova.ai

TP517 : Characteristics and Outcomes in Patients With Atrial Fibrillation (af) Receiving Direct Oral Anticoagulants (doacs) in off-Label Dose

Researchers

Presenter

  • Mary S Vaughan Sarrazin

Principal Investigators

  • Alexandros Briasoulis

  • Enrique C Leira

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Deep vein thrombosis

  • Arrhythmia

  • Pulmonary embolism

  • Venous thrombosis

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • Pradax

Outcome

  • N/A

Study Design

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved